- Home
- NCPL vs BFRI Comparison
NCPL vs BFRI Comparison
Compare NCPL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- BFRI
- Stock Information
- Founded
- NCPL 1984
- BFRI 1997
- Country
- NCPL United States
- BFRI United States
- Employees
- NCPL N/A
- BFRI N/A
- Industry
- NCPL Investment Managers
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- NCPL Finance
- BFRI Health Care
- Exchange
- NCPL Nasdaq
- BFRI Nasdaq
- Market Cap
- NCPL 9.1M
- BFRI 7.9M
- IPO Year
- NCPL N/A
- BFRI 2021
- Fundamental
- Price
- NCPL $2.34
- BFRI $0.86
- Analyst Decision
- NCPL
- BFRI Strong Buy
- Analyst Count
- NCPL 0
- BFRI 1
- Target Price
- NCPL N/A
- BFRI $2.75
- AVG Volume (30 Days)
- NCPL 205.7K
- BFRI 367.7K
- Earning Date
- NCPL 09-11-2025
- BFRI 11-12-2025
- Dividend Yield
- NCPL N/A
- BFRI N/A
- EPS Growth
- NCPL N/A
- BFRI N/A
- EPS
- NCPL N/A
- BFRI N/A
- Revenue
- NCPL $869,460.00
- BFRI $39,188,000.00
- Revenue This Year
- NCPL $739.37
- BFRI $11.07
- Revenue Next Year
- NCPL N/A
- BFRI $11.20
- P/E Ratio
- NCPL N/A
- BFRI N/A
- Revenue Growth
- NCPL N/A
- BFRI 11.20
- 52 Week Low
- NCPL $1.41
- BFRI $0.54
- 52 Week High
- NCPL $8.75
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- NCPL 49.13
- BFRI 47.35
- Support Level
- NCPL $1.77
- BFRI $0.81
- Resistance Level
- NCPL $2.34
- BFRI $0.86
- Average True Range (ATR)
- NCPL 0.19
- BFRI 0.06
- MACD
- NCPL 0.11
- BFRI -0.00
- Stochastic Oscillator
- NCPL 74.03
- BFRI 39.93
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.